101 related articles for article (PubMed ID: 8528701)
1. Antisense oligodeoxynucleotides to the kappa-1 receptor block the antinociceptive effects of delta 9-THC in the spinal cord.
Pugh G; Abood ME; Welch SP
Brain Res; 1995 Aug; 689(1):157-8. PubMed ID: 8528701
[TBL] [Abstract][Full Text] [Related]
2. Antisense oligodeoxynucleotide to a delta-opioid receptor selectively blocks the spinal antinociception induced by delta-, but not mu- or kappa-opioid receptor agonists in the mouse.
Tseng LF; Collins KA; Kampine JP
Eur J Pharmacol; 1994 Jun; 258(1-2):R1-3. PubMed ID: 7925585
[TBL] [Abstract][Full Text] [Related]
3. Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids.
Miaskowski C; Levine JD
Brain Res; 1992 Nov; 595(1):32-8. PubMed ID: 1334770
[TBL] [Abstract][Full Text] [Related]
4. Blockade of U50,488H analgesia by antisense oligodeoxynucleotides to a kappa-opioid receptor.
Chien CC; Brown G; Pan YX; Pasternak GW
Eur J Pharmacol; 1994 Mar; 253(3):R7-8. PubMed ID: 8200413
[TBL] [Abstract][Full Text] [Related]
5. Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice.
Smith PB; Welch SP; Martin BR
J Pharmacol Exp Ther; 1994 Mar; 268(3):1381-7. PubMed ID: 8138952
[TBL] [Abstract][Full Text] [Related]
6. The effect of pretreatment with a delta 2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta 2-opioid receptor agonist in the mouse spinal cord.
Narita M; Mizoguchi H; Kampine JP; Tseng LF
Br J Pharmacol; 1997 Feb; 120(4):587-92. PubMed ID: 9051295
[TBL] [Abstract][Full Text] [Related]
7. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
[TBL] [Abstract][Full Text] [Related]
8. Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice.
Welch SP
J Pharmacol Exp Ther; 1993 May; 265(2):633-40. PubMed ID: 8388455
[TBL] [Abstract][Full Text] [Related]
9. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of [D-Ala2, Glu4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor.
Bilsky EJ; Bernstein RN; Pasternak GW; Hruby VJ; Patel D; Porreca F; Lai J
Life Sci; 1994; 55(2):PL37-43. PubMed ID: 8015351
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive and motor effects of delta/mu and kappa/mu combinations of intrathecal opioid agonists.
Miaskowski C; Sutters KA; Taiwo YO; Levine JD
Pain; 1992 Apr; 49(1):137-144. PubMed ID: 1317544
[TBL] [Abstract][Full Text] [Related]
12. Antisense oligodeoxynucleotide to a delta-opioid receptor blocks the antinociception induced by cold water swimming.
Mizoguchi H; Narita M; Nagase H; Tseng LF
Regul Pept; 1995 Oct; 59(2):255-9. PubMed ID: 8584762
[TBL] [Abstract][Full Text] [Related]
13. Antisense oligodeoxynucleotide to a delta-opioid receptor given intrathecally blocks i.c.v. administered beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
Life Sci; 1994; 55(7):PL127-31. PubMed ID: 8041224
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of antisense oligodeoxynucleotides directed against g(zalpha) and g(oalpha) on antinociception produced by spinal opioid and alpha(2) adrenergic receptor agonists.
Karim F; Roerig SC
Pain; 2000 Aug; 87(2):181-191. PubMed ID: 10924811
[TBL] [Abstract][Full Text] [Related]
15. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
16. Effects of histamine receptor antagonists injected intrathecally on antinociception induced by opioids administered intracerebroventricularly in the mouse.
Suh HW; Chung KM; Kim YH; Huh SO; Song DK
Neuropeptides; 1999 Apr; 33(2):121-9. PubMed ID: 10657481
[TBL] [Abstract][Full Text] [Related]
17. Distinct antinociceptive actions mediated by different opioid receptors in the region of lamina I and laminae III-V of the dorsal horn of the rat.
Hope PJ; Fleetwood-Walker SM; Mitchell R
Br J Pharmacol; 1990 Oct; 101(2):477-83. PubMed ID: 2175238
[TBL] [Abstract][Full Text] [Related]
18. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350
[TBL] [Abstract][Full Text] [Related]
19. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
Bilsky EJ; Bernstein RN; Hruby VJ; Rothman RB; Lai J; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
Machelska H; Labuz D; Przewłocki R; Przewłocka B
J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
